These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 34402529

  • 1. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH, Hong JH, Choi YL, Lee JA, Seo MK, Lee MS, An SB, Sung MJ, Cho NY, Kim SS, Shin YK, Kim S, Kang GH.
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [Abstract] [Full Text] [Related]

  • 2. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH, Bae JM, Cho NY, Kang GH.
    Oncotarget; 2016 Mar 22; 7(12):14095-111. PubMed ID: 26883113
    [Abstract] [Full Text] [Related]

  • 3. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
    Bocciarelli C, Caumont C, Samaison L, Cariou M, Aline-Fardin A, Doucet L, Roudié J, Terris B, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Hum Pathol; 2021 Aug 22; 114():99-109. PubMed ID: 34019865
    [Abstract] [Full Text] [Related]

  • 4. NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
    Chou A, Fraser T, Ahadi M, Fuchs T, Sioson L, Clarkson A, Sheen A, Singh N, Corless CL, Gill AJ.
    Mod Pathol; 2020 May 22; 33(5):924-932. PubMed ID: 31792356
    [Abstract] [Full Text] [Related]

  • 5. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA.
    Am J Surg Pathol; 2006 Dec 22; 30(12):1491-501. PubMed ID: 17122504
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T, Akazawa Y, Yatagai N, Hiromoto T, Sasahara N, Saito T, Sakamoto N, Nagahara A, Yao T.
    Diagn Pathol; 2018 Nov 20; 13(1):88. PubMed ID: 30458818
    [Abstract] [Full Text] [Related]

  • 7. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.
    Int J Cancer; 2015 Sep 15; 137(6):1258-68. PubMed ID: 25703934
    [Abstract] [Full Text] [Related]

  • 8. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 15; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.
    Int J Cancer; 2014 Dec 01; 135(11):2507-15. PubMed ID: 24752710
    [Abstract] [Full Text] [Related]

  • 10. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Zhang Z, Pang J, Chen L, Chen J, Li J, Liu H, Wang J, Wu H, Liang Z.
    Hum Pathol; 2022 Nov 01; 129():21-31. PubMed ID: 35977594
    [Abstract] [Full Text] [Related]

  • 11. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F, Mariette C, Vincent A, Wacrenier A, Maunoury V, Leclerc J, Coppin L, Crépin M, Van Seuningen I, Leteurtre E, Buisine MP.
    Int J Cancer; 2016 Mar 15; 138(6):1472-81. PubMed ID: 26476272
    [Abstract] [Full Text] [Related]

  • 12. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 15; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.
    BMC Cancer; 2008 Sep 09; 8():255. PubMed ID: 18782444
    [Abstract] [Full Text] [Related]

  • 15. Evolving pathologic concepts of serrated lesions of the colorectum.
    Kim JH, Kang GH.
    J Pathol Transl Med; 2020 Jul 09; 54(4):276-289. PubMed ID: 32580537
    [Abstract] [Full Text] [Related]

  • 16. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN, Lai JCW, Ho SL, Leung WK, Law WL, Lee JFY, Chan AKW, Tsui WY, Chan ASY, Lee BCH, Yue SSK, Man AHY, Clevers H, Yuen ST, Leung SY.
    Gut; 2017 Sep 09; 66(9):1645-1656. PubMed ID: 27329244
    [Abstract] [Full Text] [Related]

  • 17. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
    Mezzapesa M, Losurdo G, Celiberto F, Rizzi S, d'Amati A, Piscitelli D, Ierardi E, Di Leo A.
    Int J Mol Sci; 2022 Apr 18; 23(8):. PubMed ID: 35457279
    [Abstract] [Full Text] [Related]

  • 18. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
    Ukkola I, Nummela P, Kero M, Tammio H, Tuominen J, Kairisto V, Kallajoki M, Haglund C, Peltomäki P, Kytölä S, Ristimäki A.
    Virchows Arch; 2022 Apr 18; 480(4):807-817. PubMed ID: 35237889
    [Abstract] [Full Text] [Related]

  • 19. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA.
    Gut; 2004 Aug 18; 53(8):1137-44. PubMed ID: 15247181
    [Abstract] [Full Text] [Related]

  • 20. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
    Zhang W, Schmitz AA, Kallionpää RE, Perälä M, Pitkänen N, Tukiainen M, Alanne E, Jöhrens K, Schulze-Rath R, Farahmand B, Zong J.
    Acta Oncol; 2024 Jul 05; 63():542-551. PubMed ID: 38967220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.